共 79 条
[1]
Wondergem M(2013)99mTc macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization J Nucl Med 54 1294-1301
[2]
Smits ML(2012)Dosimetry based on 99mTcmacroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results J Nucl Med 53 255-263
[3]
Elschot M(2017)Correlation of technetium-99m macroaggregated albumin and Yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: a retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography/CT J Vasc Interv Radiol 28 722-730
[4]
Garin E(2015)PET/CT-based dosimetry in 90Y-microsphere selective internal radiation therapy: single cohort comparison with pretreatment planning on (99m)Tc-MAA imaging and correlation with treatment efficacy Medicine. 94 e945-1678
[5]
Lenoir L(2016)Partition model based 99mTc-MAA SPECT/CT predictive dosimetry compared to 90Y TOF PET/CT post-treatment dosimetry in radioembolisation of hepatocellular carcinoma: a quantitative agreement comparison J Nucl Med 57 1672-269
[6]
Rolland Y(2013)Post-radioembolization yttrium-90 PET/CT-part 2: dose-response and tumor predictive dosimetry for resin microspheres EJNMMI Res 3 57-4845
[7]
Haste P(2015)Radioembolization dosimetry: the road ahead Cardiovasc Intervent Radiol 38 261-1222
[8]
Tann M(2018)Intra-arterial TheraSphere yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma: protocol for the STOP-HCC phase 3 randomized controlled trial JMIR Res Protoc 7 e11234-302
[9]
Persohn S(2011)Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for Med Phys 38 4824-1662
[10]
Song YS(2015)Y microsphere brachytherapy in the treatment of hepatic malignancies Eur J Nucl Med Mol Imaging 42 1202-7159